Apr 24 2023
Perspective
Vaccines are nothing short of miraculous. With a tiny amount of information, vaccines trigger our immune systems to develop defenses that neutralize deadly diseases - enabling us to prevent and …
Mar 27 2023
Perspective
Researcher Neil Lewis Jr. discusses how the Social Science Research Council’s Mercury Project‘s team’s approach to research can improve the evidence generation process. Where do we go from here? And how …
Mar 20 2023
Statements
The Rockefeller Foundation welcomes the announcement by COP28 Director-General Ambassador Majid Al Suwaidi on the first-ever Health Day at the 28th meeting of the Conference of the Parties (COP28) in …
Mar 15 2023
Extreme weather coupled with misinformation fuels the worst cholera outbreaks in Malawi’s history.
Feb 21 2023
Press Releases
Plan Would Accelerate a New Approach to Coronavirus Vaccines Research and Development to Protect Against Covid-19 Variants and Future Pandemic Threats From New Coronaviruses MINNEAPOLIS/ST. PAUL | February 21, 2022 ― …
Feb 15 2023
Project ACT is a public-private partnership that provides a Covid-19 testing channel for overburdened state health departments while empowering individuals and building community confidence in public health systems.
Feb 15 2023
Press Releases
Agreement Brokered by The Rockefeller Foundation’s Public Charity RF Catalytic Capital Keeps Per-test Price Under $7, Commitments from States Now Total $33.2 Million NEW YORK | February 15, 2023 ― The …
Feb 13 2023
Press Releases
RIO DE JANEIRO, BRAZIL | February 13, 2023 ― Researchers from the Centre for Data and Knowledge Integration for Health and the Federal University of Rio de Janeiro (UFRJ) unveiled …
Feb 02 2023
Press Releases
NEW DELHI | February 2, 2023 ― The Centre for Cellular and Molecular Platforms (C-CAMP) has launched the National Diagnostics Catapult (C-CAMP InDx 2.0) in New Delhi today in presence of …
Jan 30 2023
This white paper summarizes the major themes and takeaways from the summit — including how to break the “boom and bust” cycles of emergency response, how to translate interest in EIDs into R&D for effective vaccines, and how to ensure that equitable access to those lifesaving technologies.
Health Global